BIOMAT Database Logo BIOMAT Database Logo

Immunological studies of Australia antigen carriers with and without liver diseases. 1973

J O Nielsen, and V Reinicke, and O Dietrichson, and V Andersen, and M Thomsen, and E Andersen

UI MeSH Term Description Entries
D007070 Immunoglobulin A Represents 15-20% of the human serum immunoglobulins, mostly as the 4-chain polymer in humans or dimer in other mammals. Secretory IgA (IMMUNOGLOBULIN A, SECRETORY) is the main immunoglobulin in secretions. IgA,IgA Antibody,IgA1,IgA2,Antibody, IgA
D007074 Immunoglobulin G The major immunoglobulin isotype class in normal human serum. There are several isotype subclasses of IgG, for example, IgG1, IgG2A, and IgG2B. Gamma Globulin, 7S,IgG,IgG Antibody,Allerglobuline,IgG(T),IgG1,IgG2,IgG2A,IgG2B,IgG3,IgG4,Immunoglobulin GT,Polyglobin,7S Gamma Globulin,Antibody, IgG,GT, Immunoglobulin
D007075 Immunoglobulin M A class of immunoglobulin bearing mu chains (IMMUNOGLOBULIN MU-CHAINS). IgM can fix COMPLEMENT. The name comes from its high molecular weight and originally was called a macroglobulin. Gamma Globulin, 19S,IgM,IgM Antibody,IgM1,IgM2,19S Gamma Globulin,Antibody, IgM
D007111 Immunity, Cellular Manifestations of the immune response which are mediated by antigen-sensitized T-lymphocytes via lymphokines or direct cytotoxicity. This takes place in the absence of circulating antibody or where antibody plays a subordinate role. Cell-Mediated Immunity,Cellular Immune Response,Cell Mediated Immunity,Cell-Mediated Immunities,Cellular Immune Responses,Cellular Immunities,Cellular Immunity,Immune Response, Cellular,Immune Responses, Cellular,Immunities, Cell-Mediated,Immunities, Cellular,Immunity, Cell-Mediated,Response, Cellular Immune
D007114 Immunization Deliberate stimulation of the host's immune response. ACTIVE IMMUNIZATION involves administration of ANTIGENS or IMMUNOLOGIC ADJUVANTS. PASSIVE IMMUNIZATION involves administration of IMMUNE SERA or LYMPHOCYTES or their extracts (e.g., transfer factor, immune RNA) or transplantation of immunocompetent cell producing tissue (thymus or bone marrow). Immunologic Stimulation,Immunostimulation,Sensitization, Immunologic,Variolation,Immunologic Sensitization,Immunological Stimulation,Sensitization, Immunological,Stimulation, Immunologic,Immunizations,Immunological Sensitization,Immunological Sensitizations,Immunological Stimulations,Sensitizations, Immunological,Stimulation, Immunological,Stimulations, Immunological,Variolations
D007122 Immunoelectrophoresis A technique that combines protein electrophoresis and double immunodiffusion. In this procedure proteins are first separated by gel electrophoresis (usually agarose), then made visible by immunodiffusion of specific antibodies. A distinct elliptical precipitin arc results for each protein detectable by the antisera.
D008213 Lymphocyte Activation Morphologic alteration of small B LYMPHOCYTES or T LYMPHOCYTES in culture into large blast-like cells able to synthesize DNA and RNA and to divide mitotically. It is induced by INTERLEUKINS; MITOGENS such as PHYTOHEMAGGLUTININS, and by specific ANTIGENS. It may also occur in vivo as in GRAFT REJECTION. Blast Transformation,Blastogenesis,Lymphoblast Transformation,Lymphocyte Stimulation,Lymphocyte Transformation,Transformation, Blast,Transformation, Lymphoblast,Transformation, Lymphocyte,Activation, Lymphocyte,Stimulation, Lymphocyte
D009578 Nitrobenzenes BENZENE derivatives carrying nitro group substituents.
D002353 Carrier State The condition of harboring an infective organism without manifesting symptoms of infection. The organism must be readily transmissible to another susceptible host. Asymptomatic Carrier State,Asymptomatic Infection Carrier,Inapparent Infection Carrier,Presymptomatic Carrier State,Presymptomatic Infection Carrier,Super-spreader Carrier,Superspreader Carrier,Asymptomatic Carrier States,Asymptomatic Infection Carriers,Carrier State, Asymptomatic,Carrier State, Presymptomatic,Carrier States,Carrier, Super-spreader,Carrier, Superspreader,Carriers, Super-spreader,Carriers, Superspreader,Inapparent Infection Carriers,Infection Carrier, Asymptomatic,Infection Carrier, Inapparent,Infection Carrier, Presymptomatic,Presymptomatic Carrier States,Presymptomatic Infection Carriers,Super spreader Carrier,Super-spreader Carriers,Superspreader Carriers
D005455 Fluorescent Antibody Technique Test for tissue antigen using either a direct method, by conjugation of antibody with fluorescent dye (FLUORESCENT ANTIBODY TECHNIQUE, DIRECT) or an indirect method, by formation of antigen-antibody complex which is then labeled with fluorescein-conjugated anti-immunoglobulin antibody (FLUORESCENT ANTIBODY TECHNIQUE, INDIRECT). The tissue is then examined by fluorescence microscopy. Antinuclear Antibody Test, Fluorescent,Coon's Technique,Fluorescent Antinuclear Antibody Test,Fluorescent Protein Tracing,Immunofluorescence Technique,Coon's Technic,Fluorescent Antibody Technic,Immunofluorescence,Immunofluorescence Technic,Antibody Technic, Fluorescent,Antibody Technics, Fluorescent,Antibody Technique, Fluorescent,Antibody Techniques, Fluorescent,Coon Technic,Coon Technique,Coons Technic,Coons Technique,Fluorescent Antibody Technics,Fluorescent Antibody Techniques,Fluorescent Protein Tracings,Immunofluorescence Technics,Immunofluorescence Techniques,Protein Tracing, Fluorescent,Protein Tracings, Fluorescent,Technic, Coon's,Technic, Fluorescent Antibody,Technic, Immunofluorescence,Technics, Fluorescent Antibody,Technics, Immunofluorescence,Technique, Coon's,Technique, Fluorescent Antibody,Technique, Immunofluorescence,Techniques, Fluorescent Antibody,Techniques, Immunofluorescence,Tracing, Fluorescent Protein,Tracings, Fluorescent Protein

Related Publications

J O Nielsen, and V Reinicke, and O Dietrichson, and V Andersen, and M Thomsen, and E Andersen
[Immunological study of carriers of Australia antigen (HBsAg)].
August 1978, Minerva medica,
J O Nielsen, and V Reinicke, and O Dietrichson, and V Andersen, and M Thomsen, and E Andersen
[Histological liver studies in healthy Australia(SH)-antigen and antibody carriers].
December 1970, Deutsche medizinische Wochenschrift (1946),
J O Nielsen, and V Reinicke, and O Dietrichson, and V Andersen, and M Thomsen, and E Andersen
Liver disease in Australia-antigen carriers.
February 1972, Lancet (London, England),
J O Nielsen, and V Reinicke, and O Dietrichson, and V Andersen, and M Thomsen, and E Andersen
[Liver biopsy in carriers of Australia antigen].
May 1972, Nederlands tijdschrift voor geneeskunde,
J O Nielsen, and V Reinicke, and O Dietrichson, and V Andersen, and M Thomsen, and E Andersen
Differential distribution of Australia-antigen-associated particles in patients with liver diseases and normal carriers.
March 1973, The New England journal of medicine,
J O Nielsen, and V Reinicke, and O Dietrichson, and V Andersen, and M Thomsen, and E Andersen
Australia antigen, immunity and chronic liver disease. The hepatological and immunological profile of Australia antigen (HBAa) carriers in a large psychiatric institution.
January 1974, Tijdschrift voor gastro-enterologie,
J O Nielsen, and V Reinicke, and O Dietrichson, and V Andersen, and M Thomsen, and E Andersen
Clinico-pathological studies of the liver in asymptomatic carriers of Australia antigen.
February 1975, Acta hepato-gastroenterologica,
J O Nielsen, and V Reinicke, and O Dietrichson, and V Andersen, and M Thomsen, and E Andersen
Australia antigen: persistence of immunological markers (d, y, w) in antigen carriers.
August 1973, Infection and immunity,
J O Nielsen, and V Reinicke, and O Dietrichson, and V Andersen, and M Thomsen, and E Andersen
The carriers of Australia-antigen. Immunological, histological and electron-microscopy study.
January 1971, Progress in immunobiological standardization,
J O Nielsen, and V Reinicke, and O Dietrichson, and V Andersen, and M Thomsen, and E Andersen
[Australia-SH antigen and liver diseases].
February 1970, Deutsche medizinische Wochenschrift (1946),
Copied contents to your clipboard!